Literature DB >> 32091079

Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).

Masahiro Seo1, Takahisa Yamada1, Shunsuke Tamaki1, Tetsuya Watanabe1, Takashi Morita1, Yoshio Furukawa1, Masato Kawasaki1, Atsushi Kikuchi1, Tsutomu Kawai1, Makoto Abe1, Jun Nakamura1, Kyoko Yamamoto1, Kiyomi Kayama1, Masatsugu Kawahira1, Kazuya Tanabe1, Takanari Kimura1, Kunpei Ueda1, Daisuke Sakamoto1, Yasushi Sakata2, Masatake Fukunami1.   

Abstract

AIMS: Cardiac 123I-metaiodobenzylguanidine (123I-MIBG) imaging provides prognostic information in patients with chronic heart failure (HF). However, there is little information available on the prognostic role of cardiac 123I-MIBG imaging in patients admitted for acute decompensated heart failure (ADHF), especially relating to reduced ejection fraction [HFrEF; left ventricular ejection fraction (LVEF) < 40%], mid-range ejection fraction (HFmrEF; 40% ≤ LVEF < 50%) and preserved ejection fraction (HFpEF; LVEF ≥ 50%). METHODS AND
RESULTS: We studied 349 patients admitted for ADHF and discharged with survival. Cardiac 123I-MIBG imaging, echocardiography, and venous blood sampling were performed just before discharge. The cardiac 123I-MIBG heart-to-mediastinum ratio (late H/M) was measured on the chest anterior view images obtained at 200 min after the isotope injection. The endpoint was cardiac events defined as unplanned HF hospitalization and cardiac death. During a follow-up period of 2.1 ± 1.4 years, 128 patients had cardiac events (45/127 in HFrEF, 28/78 in HFmrEF, and 55/144 in HFpEF). On multivariable Cox analysis, late H/M was significantly associated with cardiac events in overall cohort (P = 0.0038), and in subgroup analysis of each LVEF subgroup (P = 0.0235 in HFrEF, P = 0.0119 in HFmEF and P = 0.0311 in HFpEF). Kaplan-Meier analysis showed that patients with low late H/M (defined by median) had significantly greater risk of cardiac events in overall cohort (49% vs. 25% P < 0.0001) and in each LVEF subgroup (HFrEF: 48% vs. 23% P = 0.0061, HFmrEF: 51% vs. 21% P = 0.0068 and HFpEF: 50% vs. 26% P = 0.0026).
CONCLUSION: Cardiac sympathetic nerve dysfunction was associated with poor outcome in ADHF patients irrespective of HFrEF, HFmrEF, or HFpEF. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  acute decompensated heart failure; cardiac 123I-MIBG imaging; heart failure with mid-range ejection fraction; risk stratification

Year:  2021        PMID: 32091079     DOI: 10.1093/ehjci/jeaa025

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  3 in total

1.  Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.

Authors:  Shunsuke Tamaki; Takahisa Yamada; Tetsuya Watanabe; Takashi Morita; Masato Kawasaki; Atsushi Kikuchi; Tsutomu Kawai; Masahiro Seo; Jun Nakamura; Kiyomi Kayama; Daisuke Sakamoto; Kumpei Ueda; Takehiro Kogame; Yuto Tamura; Takeshi Fujita; Keisuke Nishigaki; Yuto Fukuda; Yuki Kokubu; Masatake Fukunami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-08       Impact factor: 10.057

2.  Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co-morbid burden in acute decompensated heart failure.

Authors:  Kiyomi Kayama; Takahisa Yamada; Shunsuke Tamaki; Tetsuya Watanabe; Takashi Morita; Yoshio Furukawa; Masato Kawasaki; Atsushi Kikuchi; Tsutomu Kawai; Masahiro Seo; Jun Nakamura; Masatsugu Kawahira; Masatake Fukunami
Journal:  ESC Heart Fail       Date:  2021-01-12

3.  Reclassification of Heart Failure with Preserved Ejection Fraction Following Cardiac Sympathetic Nervous System Activation: A New Cutoff Value of 58.

Authors:  Toshihiko Goto; Takafumi Nakayama; Junki Yamamoto; Kento Mori; Yasuhiro Shintani; Shohei Kikuchi; Hiroshi Fujita; Hidekatsu Fukuta; Yoshihiro Seo
Journal:  Tomography       Date:  2022-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.